
Event moderator Jesse McCullough, PharmD, wraps up the Total Pharmacy Solutions Summit Spring 2026 event with key takeaways and insights into the evolving road pharmacy is headed on.

Event moderator Jesse McCullough, PharmD, wraps up the Total Pharmacy Solutions Summit Spring 2026 event with key takeaways and insights into the evolving road pharmacy is headed on.

Blair Thielemier, PharmD, EQUIPP customer success manager at PQS by Innovaccer, offers insight into key technology being used to realize greater revenue for pharmacy businesses.

Timothy Aungst, PharmD, and Ravi Patel, PharmD, MBA, MS, unpack the role of direct-to-patient in the current pharmacy landscape.

The question facing many independents is no longer whether vaccines matter but whether a vaccine program is truly right for their pharmacy.

Ketan Mehta, CEO and president of PrimeRx, presented a keynote session on helping independent pharmacies diversify purchasing, improve cash flow, and reduce the cost of goods sold.

In this episode, host Taylor Watterson, PharmD, PhD, welcomes Emily Hoffins, MS, PhD, postdoctoral researcher in the SCRPTS Lab at the University of Illinois Chicago Retzky College of Pharmacy.

This episode highlights the landmark FTC settlement with Express Scripts and what independent pharmacies and plan sponsors can expect going forward.

In Texas community pharmacies, researchers assess the communication concordance between pharmacists and patients during medication counseling.


Many states are pushing pharmacies to move beyond the traditional dispensing role into more robust clinical care.

From proposed transparency rules to Medicare price negotiation programs, the stakes are high for pharmacy reimbursement and the sustainability of independent practices.

From patient perspectives on acceptability, researchers assess the impact of pharmacist-led point-of-care testing services in rural Tennessee communities.

Amid increased use of artificial intelligence across pharmacy, researchers assess pharmacists’ propensity to trust the emerging automated technology.

With drug shortages continuing to disrupt patient care and pharmacy operations, Lani Bertrand breaks down how AI and automation are reshaping the way pharmacies respond to supply chain disruptions.

A study finds prior-authorization bans do not boost buprenorphine retention for patients on private insurance.

Drug shortages remain one of the most persistent challenges in pharmacy practice, but emerging technologies like AI are beginning to shift the landscape for pharmacies and public health as a whole.

This episode explores a specific generalization within pharmacy practice that leaders should actively avoid while simultaneously looking toward overcoming key hurdles affecting team members.

Lani Bertrand, senior director of clinical marketing & thought leadership at Omnicell, discusses the consistent drivers of drug shortages in the US.

With its initial rollout beginning in 2026, the Medicare Drug Price Negotiation Program has caused significant strain on the cash flow of independent pharmacies.

With a key exemption under DSCSA expiring at the end of the year, Matt Sample from Cencora helps pharmacies understand the tools and processes they need now to best comply with the law.

Matt Sample, senior vice president of manufacturer, quality, and replenishment operations at Cencora, discusses DSCSA compliance hurdles, VRS tools, and a new push toward 12-digit NDCs.

Matt Sample from Cencora discusses current DSCSA developments on the rise for pharmacy businesses in 2026—namely small dispensers that have been under exemption.

The event will explore how community pharmacy leaders can improve profitability, business resilience, as well as PBM and reimbursement challenges.

In this episode, host Taylor Watterson, PharmD, PhD, welcomes Mohammad Al Numan, BS, MS, a 2025-27 University of Illinois Chicago/Takeda Fellow in Health Economics and Outcomes Research.

Just before monumental PBM reform was signed into law, as well as a landmark settlement between the FTC and Express Scripts, the Department of Labor proposed its own set of PBM regulations.

Tennessee’s 2024 expansion of pharmacist's scope of practice authorizes independent prescribing and test-and-treat services, positioning pharmacists as primary care extenders in underserved communities.